2022
DOI: 10.3390/vaccines10040484
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the Thermal Stability of a Vaccine Prototype Based on Virus-like Particle Formulated HIV-1 Envelope

Abstract: The long-term storage stability of vaccines has a major impact on the roll-out and success of global immunization programs. For the Human Immunodeficiency Virus type 1 (HIV-1) virus-like particle (VLP) vaccine prototype evaluated here, nanoparticle tracking analysis (NTA), and enzyme-linked immunoabsorbent assay (ELISA) results demonstrated a remarkable structural stability. VLPs maintained their integrity and the recognition of relevant B-cell epitopes for three months at 4 and −20 °C. Interestingly, most par… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 14 publications
0
2
0
Order By: Relevance
“…Comparative Analysis. Compared to freeze-drying and genetic engineering to improve the thermal stability of influenza vaccine, 27 human immunodeficiency virus type 1 vaccine, 60 and classical swine fever vaccine, 61 HSZ does not require a complex preparation process, can be performed in a short time, and is cost-effective (Table S2). Long-term stability is also a key factor in the use of vaccines, and this part of the study is the focus of our subsequent research.…”
Section: ■ Experimental Sectionmentioning
confidence: 99%
“…Comparative Analysis. Compared to freeze-drying and genetic engineering to improve the thermal stability of influenza vaccine, 27 human immunodeficiency virus type 1 vaccine, 60 and classical swine fever vaccine, 61 HSZ does not require a complex preparation process, can be performed in a short time, and is cost-effective (Table S2). Long-term stability is also a key factor in the use of vaccines, and this part of the study is the focus of our subsequent research.…”
Section: ■ Experimental Sectionmentioning
confidence: 99%
“…With the accelerated advancement of nanotechnology and protein engineering, interesting capabilities have been developed for the development and improvement of vaccines and epitope presentation or drug delivery systems (DDSs). Therefore, one possible design inserting carbonbased nanomaterials (CBNs) to induce the synthesis of speci c metabolic pathways, has become an attractive alternative for many researchers in the design and development of novel nanovaccines [28,31,32].…”
Section: What Are the Technological Strategies Advances And Challenge...mentioning
confidence: 99%